Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin US Core Bond ETF
FLCB
|
+$697M |
| 2 |
Verizon
VZ
|
+$437M |
| 3 |
Merck
MRK
|
+$411M |
| 4 |
Franklin US Treasury Bond ETF
FLGV
|
+$370M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.17B |
| 2 |
RTN
Raytheon Company
RTN
|
+$831M |
| 3 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$566M |
| 4 |
Gilead Sciences
GILD
|
+$499M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$463M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.52% |
| 2 | Healthcare | 15.75% |
| 3 | Financials | 10.84% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WIRE
851
DELISTED
Encore Wire Corp
WIRE
| $8.93M | ﹤0.01% |
178,222
+811
| +0.5% | +$37.2K |
|
852
Pliant Therapeutics
PLRX
$67.5M
| $8.92M | ﹤0.01% |
+350,000
| New | +$9.29M |
|
853
Revolution Medicines
RVMD
$40.2B
| $8.82M | ﹤0.01% |
350,070
+70
| +0% | +$2.2K |
|
854
BridgeBio Pharma
BBIO
$16.5B
| $8.75M | ﹤0.01% |
283,300
| – | – |
|
|
AUTL
855
Autolus Therapeutics
AUTL
$386M
| $8.75M | ﹤0.01% |
545,455
| – | – |
|
856
Akamai
AKAM
$16.8B
| $8.66M | ﹤0.01% |
76,075
+3,221
| +4% | +$324K |
|
857
Tyson Foods
TSN
$20.2B
| $8.62M | ﹤0.01% |
142,736
-25,538
| -15% | -$1.55M |
|
858
Black Diamond Therapeutics
BDTX
$101M
| $8.52M | ﹤0.01% |
300,070
| – | – |
|
859
Precision BioSciences
DTIL
$188M
| $8.52M | ﹤0.01% |
34,339
-2,566
| -7% | -$562K |
|
|
HES
860
DELISTED
Hess
HES
| $8.49M | ﹤0.01% |
162,980
-15,688
| -9% | -$718K |
|
861
Grupo Cibest SA
CIB
$20.4B
| $8.45M | ﹤0.01% |
303,947
-74,700
| -20% | -$1.96M |
|
862
Boston Properties
BXP
$11B
| $8.36M | ﹤0.01% |
89,729
-8,355
| -9% | -$758K |
|
863
Vanguard S&P 500 ETF
VOO
$968B
| $8.34M | ﹤0.01% |
27,758
-160,263
| -85% | -$43.1M |
|
864
Unilever
UL
$131B
| $8.26M | ﹤0.01% |
131,393
+70,770
| +117% | +$4.23M |
|
865
American Coastal Insurance
ACIC
$498M
| $8.19M | ﹤0.01% |
1,056,534
| – | – |
|
866
iShares S&P 500 Growth ETF
IVW
$72.5B
| $8.11M | ﹤0.01% |
146,756
+88,236
| +151% | +$4.23M |
|
867
J.M. Smucker
SJM
$12.6B
| $8.1M | ﹤0.01% |
75,261
+23,294
| +45% | +$2.62M |
|
|
WPX
868
DELISTED
WPX Energy, Inc.
WPX
| $8.06M | ﹤0.01% |
1,311,000
+494,100
| +60% | +$2.79M |
|
869
Progressive
PGR
$124B
| $8.06M | ﹤0.01% |
89,746
+54,368
| +154% | +$4.24M |
|
870
Arq
ARQ
$86.7M
| $8.05M | ﹤0.01% |
1,724,689
-40
| -0% | -$230 |
|
871
iShares MSCI South Korea ETF
EWY
$21.7B
| $8.03M | ﹤0.01% |
134,066
-13,006
| -9% | -$686K |
|
|
DOC
872
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8M | ﹤0.01% |
452,921
-43,446
| -9% | -$709K |
|
873
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $7.99M | ﹤0.01% |
184,707
+116,815
| +172% | +$4.32M |
|
874
UNIFI
UFI
$117M
| $7.98M | ﹤0.01% |
626,069
+2,007
| +0.3% | +$23.8K |
|
|
API
875
Agora
API
$326M
| $7.97M | ﹤0.01% |
+170,087
| New | +$8.03M |
|
Similar funds
Franklin Resources's Q2 2020 Portfolio in Review
As of Q2 2020, Franklin Resources held 1,773 positions worth $194B, up 30% from $150B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Franklin Resources's Q2 2020 filing shows 304 new, 648 increased, 578 reduced and 97 closed positions. Its largest new stake was Franklin US Treasury Bond ETF: 14,676,171 shares worth $374M. The largest sale was Allergan plc, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Franklin Resources's largest Q2 2020 buy was Franklin US Treasury Bond ETF: 14,676,171 shares worth $374M.
- Franklin Resources added most to Franklin US Core Bond ETF in Q2 2020, an estimated $697M increase.
- Franklin Resources's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $499M.
- Franklin Resources fully exited Allergan plc in Q2 2020, selling an estimated $1.17B.
- Franklin Resources's ten largest holdings make up 13% of its $194B portfolio in Q2 2020.
- Franklin Resources opened 304 new positions and closed 97 in Q2 2020.
- Franklin Resources's portfolio value rose 30% quarter-over-quarter to $194B.
Based on Franklin Resources's 13F filing for Q2 2020, filed 13 Aug 2020.